News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
680,340 Results
Type
Article (66691)
Company Profile (208)
Press Release (613429)
Multimedia
Podcasts (158)
Webinars (25)
Section
Business (183535)
Career Advice (2317)
Deals (29369)
Drug Delivery (122)
Drug Development (78598)
Employer Resources (143)
FDA (14925)
Job Trends (13963)
News (312294)
Policy (28972)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2936)
Academic (2)
Accelerated approval (36)
Adcomms (29)
Allergies (145)
Alliances (49484)
ALS (183)
Alzheimer's disease (1704)
Antibody-drug conjugate (ADC) (379)
Approvals (15180)
Artificial intelligence (606)
Autoimmune disease (198)
Automation (40)
Bankruptcy (256)
Best Places to Work (10935)
BIOSECURE Act (20)
Biosimilars (163)
Biotechnology (146)
Bladder cancer (179)
Brain cancer (69)
Breast cancer (709)
Cancer (5404)
Cardiovascular disease (409)
Career advice (1965)
Career pathing (38)
CAR-T (305)
CDC (57)
Celiac Disease (1)
Cell therapy (819)
Cervical cancer (42)
Clinical research (66665)
Collaboration (1899)
Company closure (6)
Compensation (682)
Complete response letters (61)
COVID-19 (2701)
CRISPR (100)
C-suite (863)
Cystic fibrosis (138)
Data (6516)
Decentralized trials (2)
Denatured (53)
Depression (143)
Diabetes (482)
Diagnostics (6601)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (40)
Drug discovery (295)
Drug pricing (186)
Drug shortages (24)
Duchenne muscular dystrophy (240)
Earnings (76207)
Editorial (61)
Employer branding (19)
Employer resources (130)
Events (103109)
Executive appointments (940)
FDA (18017)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1505)
Gene editing (200)
Generative AI (57)
Gene therapy (620)
GLP-1 (928)
Government (4342)
Grass and pollen (7)
Guidances (384)
Healthcare (18180)
HIV (68)
Huntington's disease (44)
IgA nephropathy (80)
Immunology and inflammation (238)
Immuno-oncology (79)
Indications (137)
Infectious disease (2988)
Inflammatory bowel disease (187)
Inflation Reduction Act (15)
Influenza (121)
Intellectual property (244)
Interviews (424)
IPO (13864)
IRA (57)
Job creations (3359)
Job search strategy (1642)
JPM (60)
Kidney cancer (19)
Labor market (81)
Layoffs (500)
Leadership (35)
Legal (6667)
Liver cancer (102)
Longevity (24)
Lung cancer (723)
Lymphoma (396)
Machine learning (43)
Management (46)
Manufacturing (815)
MASH (177)
Medical device (11879)
Medtech (11937)
Mergers & acquisitions (16533)
Metabolic disorders (1222)
mRNA (184)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (340)
Neuropsychiatric disorders (89)
Neuroscience (2974)
Neurotech (1)
NextGen: Class of 2026 (6173)
Non-profit (4773)
Now hiring (54)
Obesity (546)
Opinion (304)
Ovarian cancer (178)
Pain (202)
Pancreatic cancer (257)
Parkinson's disease (298)
Partnered (34)
Patents (466)
Patient recruitment (536)
Peanut (54)
People (53006)
Pharmaceutical (44)
Pharmacy benefit managers (23)
Phase 1 (20949)
Phase 2 (29035)
Phase 3 (21848)
Pipeline (6115)
Policy (316)
Postmarket research (2848)
Preclinical (9602)
Press Release (70)
Prostate cancer (279)
Psychedelics (51)
Radiopharmaceuticals (312)
Rare diseases (881)
Real estate (5742)
Recruiting (60)
Regulatory (22427)
Reports (42)
Research institute (2701)
Resumes & cover letters (352)
Rett syndrome (25)
RNA editing (13)
RSV (79)
Schizophrenia (148)
Series A (248)
Series B (177)
Service/supplier (13)
Sickle cell disease (101)
Special edition (28)
Spinal muscular atrophy (146)
Sponsored (44)
Startups (3276)
State (2)
Stomach cancer (21)
Supply chain (99)
Tariffs (74)
The Weekly (103)
Vaccines (1068)
Venture capital (81)
Weight loss (341)
Women's health (99)
Worklife (19)
Date
Today (20)
Last 7 days (589)
Last 30 days (2668)
Last 365 days (28198)
2026 (5861)
2025 (28515)
2024 (32640)
2023 (36989)
2022 (48262)
2021 (52066)
2020 (50180)
2019 (43564)
2018 (33089)
2017 (30680)
2016 (30564)
2015 (35826)
2014 (29496)
2013 (26291)
2012 (26751)
2011 (26802)
2010 (25693)
Location
Africa (898)
Alabama (90)
Alaska (7)
Arizona (259)
Arkansas (13)
Asia (41065)
Australia (7357)
California (10602)
Canada (3062)
China (1160)
Colorado (464)
Connecticut (497)
Delaware (334)
Europe (95138)
Florida (1638)
Georgia (358)
Hawaii (2)
Idaho (48)
Illinois (823)
India (75)
Indiana (488)
Iowa (21)
Japan (454)
Kansas (114)
Kentucky (47)
Louisiana (33)
Maine (45)
Maryland (1378)
Massachusetts (7679)
Michigan (315)
Minnesota (546)
Mississippi (6)
Missouri (119)
Montana (28)
Nebraska (23)
Nevada (111)
New Hampshire (89)
New Jersey (3062)
New Mexico (31)
New York (3000)
North Carolina (1453)
North Dakota (8)
Northern California (5231)
Ohio (310)
Oklahoma (20)
Oregon (39)
Pennsylvania (2167)
Puerto Rico (17)
Rhode Island (43)
South America (1192)
South Carolina (59)
Southern California (4145)
Tennessee (180)
Texas (1740)
United States (38569)
Utah (329)
Vermont (1)
Virginia (255)
Washington D.C. (77)
Washington State (945)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
680,340 Results for "h lee moffitt cancer center and research institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
January 20, 2026
·
11 min read
Press Releases
NYU Langone Health Announces Gastrointestinal Cancer and Translational Research Leader Dr. Anirban Maitra as New Director of the Perlmutter Cancer Center
January 29, 2026
·
5 min read
Press Releases
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer
June 26, 2025
·
4 min read
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Press Releases
NYU Langone Perlmutter Cancer Center Names Leading Clinician-Researcher as New Chair of Radiation Oncology
February 10, 2026
·
3 min read
Press Releases
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
March 4, 2026
·
15 min read
Press Releases
Parker Institute for Cancer Immunotherapy Collaborates with Conquer Cancer and ASCO to Support Promising Cancer Research
January 29, 2026
·
3 min read
Press Releases
Northwell Health and START Center for Cancer Research unveil world-class early-phase cancer clinical trial center
December 18, 2025
·
5 min read
Press Releases
PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics
August 21, 2025
·
3 min read
Press Releases
MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute
March 4, 2026
·
4 min read
1 of 68,034
Next
